Recent News

Consultation on exposure draft for exclusion of gambling and tobacco companies under the R&D Tax Incentive

February 9th, 2026

The December 2024 Mid‑Year Economic and Fiscal Outlook (MYEFO) was released by the Government on 18 December 2024 and announced that The Government will exclude activities related to gambling and tobacco from Research and Development Tax Incentive eligibility for income years starting on or after 1 July 2025. The Government then released an exposure draft in December 2025, releasing Treasury Laws Amendment Bill 2025: Exclusion of tobacco and gambling related activities from the Research and Development Tax Incentive which is the legislative instrument that would […]

Read More

DISR update notes applications lodged well before deadline subject to faster processing (take action now for FY25 deadline)

February 2nd, 2026

The deadline for FY25 R&D Claims (for the YE 30 June 2025) is fast approaching.  ⠀ Similar to last year, in an update published in late January, The  Department of Industry, Science and Resources (DISR) have confirmed that leaving lodgement until close to the deadline will understandably lead to longer processing times for R&D Registrations:  ⠀ The January 2026 update notes: ‘We recommend lodging your application for the 2024-25 financial year now, instead of waiting until the end of April.The time […]

Read More

Significant Refundable R&D Offsets receipts reported to the ASX in recent months to January 2026

January 19th, 2026

Over recent months, a number of companies have reported to the ASX receipt of substantial Refundable R&D Tax Offsets. Notable receipts include: Recce Pharmaceuticals (ASX: RCE) received $5.34 M related to its anti-infective platform; Race Oncology (ASX:RAC) received $2.8M related to its cancer treatments; Ecograf (ASX: EGR) received $1.7M related to its EcoGraf HFfree proprietary purification technology; Chimeric Therapeutics (ASX: CHM)  received $4.5M related to its cancer treatments; Elixir Energy (ASX: EXR) received $3.8M related to its unconventional gas project […]

Read More

R&D Tax Incentive – Potential Key Events in 2026

January 7th, 2026

Some key events impacting Australia’s R&D Tax Incentive over the past 12 months during calendar year 2025 included: The release of proposed legislation to exclude gambling and tobacco companies from eligibility under the R&D Tax Incentive; The strategic examination and review of Australia’s Research and Development (R&D) system progressed and released a discussion paper on R&D Incentives that contained some significant potential changes for consideration. Swanson Reed made a submission to both the general review and the discussion paper on R&D Incentives; A new R&D Tax Incentive registration […]

Read More

Categories

Archives